Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model

Cytokine

Volumn 49, Issue 3, 2010, Pages 287-293

  Kalaaji, Amer N ^a   Lu, Jun ^a   Markovic, Svetomir N ^a   Celis, Esteban ^b   Pittelkow, Mark R ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Cytokines; Cytotoxic T lymphocytes; Melanoma; Therapy; Tumor

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL LINE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; IMMUNOREACTIVITY; IN VIVO STUDY; LYMPH NODE; LYMPHADENOPATHY; MELANOMA; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR NECROSIS; TUMOR REGRESSION;

ADAPTIVE IMMUNITY; ANIMALS; CELL LINE, TUMOR; CYTOKINES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY; INTERFERON-ALPHA; LYMPHOCYTE ACTIVATION; MALE; MELANOMA; MICE; MICE, INBRED C57BL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 75449110531     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.11.016     Document Type: Article

References (26)

1. SEER Cancer Statistics Review, 1975-2002 [database on the Internet]. Bethesda (MD): National Cancer Institute; 2002. Available from: http://seer.cancer.gov/csr/1975_2002/ [cited 2007 Feb 19].
2. Parkinson D.R., Abrams J.S., Wiernik P.H., Rayner A.A., Margolin K.A., Van Echo D.A., et al. Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study. J Clin Oncol 8 (1990) 1650-1656
3. Isaacs A., and Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147 (1957) 258-267
4. + T cells. Immunol Rev 211 (2006) 81-92
5. Hakansson A., Gustafsson B., Krysander L., and Hakansson L. Effect of IFN-α on tumor-infiltrating mononuclear cells and regressive changes in metastatic malignant melanoma. J Interferon Cytokine Res 18 (1998) 33-39
6. Slaton J.W., Perrotte P., Inoue K., Dinney C.P., and Fidler I.J. Interferon-α-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. Clin Cancer Res 5 (1999) 2726-2734
7. Kirkwood J.M., Ibrahim J.G., Sondak V.K., Richards J., Flaherty L.E., Ernstoff M.S., et al. High- and low-dose interferon α-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 18 (2000) 2444-2458
8. Kirkwood J.M., Ibrahim J.G., Sosman J.A., Sondak V.K., Agarwala S.S., Ernstoff M.S., et al. High-dose interferon α-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol 19 (2001) 2370-2380
9. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J Immunol 154 (1995) 5851-5861
10. Szabolcs P., Avigan D., Gezelter S., Ciocon D.H., Moore M.A., Steinman R.M., et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood 87 (1996) 4520-4530
11. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 182 (1995) 1111-1119 Erratum in: J Exp Med 1996;135:1276-7
12. Vaquerano J.E., Cadbury P., Treseler P., Sagebiel R., and Leong S.P. Regression of in-transit melanoma of the scalp with intralesional recombinant human granulocyte-macrophage colony-stimulating factor. Arch Dermatol 135 (1999) 1276-1277
13. Hoeller C., Jansen B., Heere-Ress E., Pustelnik T., Mossbacher U., Schlagbauer-Wadl H., et al. Perilesional injection of r-GM-CSF in patients with cutaneous melanoma metastases. J Invest Dermatol 117 (2001) 371-374
14. Cybulsky M.I., McComb D.J., and Movat H.Z. Neutrophil leukocyte emigration induced by endotoxin: mediator roles of interleukin 1 and tumor necrosis factor α 1. J Immunol 140 (1988) 3144-3149
15. Kalaaji A.N., McCullough K., and Hay J.B. The enhancement of lymphocyte localization in skin sites of sheep by tumor necrosis factor α. Immunol Lett 23 (1989) 143-147
16. Kimber I., and Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-α). J Invest Dermatol 99 (1992) 48S-50S
17. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., and Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72 (1975) 3666-3670
18. Old L.J. Tumor necrosis factor (TNF). Science 230 (1985) 630-632
19. van Der Veen A.H., ten Hagen T.L., de Wilt J.H., van Ijken M.G., and Eggermont A.M. An overview on the use of TNF-α: our experience with regional administration and developments towards new opportunities for systemic application. Anticancer Res 20 (2000) 3467-3474
20. Rossi C.R., Foletto M., Mocellin S., Pilati P., and Lise M. Hyperthermic isolated limb perfusion with low-dose tumor necrosis factor-α and melphalan for bulky in-transit melanoma metastases. Ann Surg Oncol 11 (2004) 173-177
21. Rubio V., Stuge T.B., Singh N., Betts M.R., Weber J.S., Roederer M., et al. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 9 (2003) 1377-1382 [Epub 2003 Oct 5]
22. Janik J.E., Miller L.L., Kopp W.C., Taub D.D., Dawson H., Stevens D., et al. Treatment with tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients. Clin Immunol 93 (1999) 209-221
23. Shurin M.R., Kirkwood J.M., and Esche C. Cytokine-based therapy for melanoma: pre-clinical studies. Forum (Genova) 10 (2000) 204-226
24. Wong G.H., and Goeddel D.V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242 4880 (1988) 941-944
25. Shen H.M., and Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 20 10 (2006) 1589-1598
26. Kirkwood J.M., Strawderman M.H., Ernstoff M.S., Smith T.J., Borden E.C., Blum R.H., et al. The Eastern Cooperative Oncology Group Trial EST 1684. Interferon α-2b adjuvant therapy of high-risk resected cutaneous melanoma. J Clin Oncol 14 (1996) 7-17